Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Nemolizumab in Atopic Dermatitis
3
Mins
March 2025
Nemolizumab is an anti-IL-31Rα monoclonal antibody that has demonstrated clinical efficacy in two global Phase III studies (ARCADIA-1 and…
Read more
10
Mins
17 Sep 2019
IL-23 Inhibition in Psoriasis: A Novel Approach to Convenient, Consistent Clearance
This sponsored symposium took place on 12th June 2019 in Milan, Italy, as part of the 24th World Congress of Dermatology (WCD), 2019
9
Mins
16 Sep 2019
Spotlight on Acne
This symposium took place on 13th June 2019, as part of the World Congress of Dermatology (WCD) symposium in Milan, Italy
9
Mins
11 Sep 2019
IL-23 Inhibition as a Key Component in Psoriasis Treatment is Here to Stay
Prof Elke de Jong focussed her presentation on data from randomised clinical trials (RCT) and real-world evidence (RWE) from psoriasis patient registries.
10
Mins
20 Aug 2019
Right Treatment to the Right Patient in Moderate-to-Severe Psoriasis: Discussion on Difference
Dermatologists frequently see psoriasis patients for whom the most troublesome symptoms are not the constant physical discomfort…
10
Mins
14 Mar 2019
Discover the Potential: Exploring New Frontiers of IL-23 Inhibitors
Affecting up to 11.4% of the population worldwide, psoriasis is one of the most common chronic autoinflammatory diseases.
10
Mins
12 Feb 2019
Translating Evidence to Practice: From Clinical Research to Real-World Experience
The goal of this programme is to support dermatologists to improve the management of patients with moderate-to-severe AD and bring together clinicians…
5
Mins
7 Feb 2019
Dimethyl Fumarate in Psoriasis Therapy
This presentation by Dr Weisenseel considered the role of fumaric acid esters (FAE) in plaque psoriasis.
9
Mins
29 Jan 2019
Unlocking the Potential of Immuno-Oncology in Advanced Cutaneous Squamous Cell Carcinoma: Role of Checkpoint Blockade
The rising incidence of CSCC presents a major challenge for healthcare systems and the frequency and impact of progression to advanced disease is…
Loading posts...
« Previous
1
…
5
6
7
8
9
…
11
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View